Filtros de búsqueda

Lista de obras de

A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19

artículo científico publicado en 2022

Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial

artículo científico publicado en 2019

Adopting PROs in virtual and outpatient management of RA

artículo científico publicado en 2020

Clinical efficacy of launched JAK inhibitors in rheumatoid arthritis

artículo científico publicado en 2019

Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis

scientific article published on 30 April 2019

Developing anti-TNF and biologic agents ⬇️

artículo científico publicado el 1 de agosto de 2011

Effect of Baricitinib and Adalimumab in Reducing Pain and Improving Function in Patients with Rheumatoid Arthritis in Low Disease Activity: Exploratory Analyses from RA-BEAM

scientific article published on 05 September 2019

Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study

scientific article published on 08 June 2019

Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or

artículo científico publicado en 2019

How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?-MTX in the Treat-to-Target Strategy.

artículo científico publicado en 2019

Human neutrophils secrete vascular endothelial growth factor ⬇️

artículo científico publicado el 1 de septiembre de 1997

Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis

artículo científico publicado en 2016

Maintenance of Efficacy and Safety with Subcutaneous Golimumab Among Patients with Active Rheumatoid Arthritis Who Previously Received Intravenous Golimumab ⬇️

artículo científico publicado el 15 de noviembre de 2011

Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease ⬇️

artículo científico publicado el 1 de abril de 1995

Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial ⬇️

artículo científico publicado el 22 de agosto de 2011

Patient Perceptions concerning Pain Management in the Treatment of Rheumatoid Arthritis ⬇️

artículo científico publicado el 1 de julio de 2010

Recent evidence for the achievement of remission in rheumatoid arthritis through early aggressive therapy ⬇️

artículo científico publicado el 10 de diciembre de 2008

Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial

scientific article published on 24 April 2019

Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients

artículo científico publicado en 2019

Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohor

scientific article published on 02 October 2019

The Development of Complex Digital Health Solutions: Formative Evaluation Combining Different Methodologies

artículo científico publicado en 2018

The Development of Complex Digital Health Solutions: Formative Evaluation Combining Different Methodologies (Preprint)

Treatment Mode Preferences in Rheumatoid Arthritis: Moving Toward Shared Decision-Making

scientific article published on 20 January 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda